Harvard Bioscience (HBIO) FCF Margin (2010 - 2026)
Harvard Bioscience (HBIO) posted quarterly FCF Margin of 5.24% for Q1 2026, down 1660.0% year-over-year from 0.34% in Q1 2025, and down 128.3% quarter-over-quarter from 2.3% in Q4 2025.
Harvard Bioscience (HBIO) FCF Margin (2010 - 2026) Analysis & Trends
Harvard Bioscience (HBIO) has reported FCF Margin for 17 consecutive years, with 5.24% the latest figure, recorded in Q1 2026.
- In Q1 2026, FCF Margin fell 1660.0% year-over-year to 5.24%; the TTM figure through Mar 2026 stood at 2.23% (up 167.0% YoY), while the FY2025 annual figure was 6.32%, up 760.0% from the prior year.
- FCF Margin retreated to 5.24% in Q1 2026 per HBIO's latest filing, from 2.3% in the prior quarter.
- Across five years, FCF Margin topped out at 16.34% in Q3 2023 and bottomed at 8.54% in Q1 2022.
- Historically, FCF Margin has averaged 3.42% across 5 years, with a median of 4.26% in 2025.
- Annual changes were most pronounced in 2024 — FCF Margin tumbled 2418 bps — and 2025, when it soared 2024 bps.
- Harvard Bioscience's FCF Margin stood at 8.6% in 2022, then jumped by 43 bps to 12.34% in 2023, then slumped by 53 bps to 5.8% in 2024, then sank by 140 bps to 2.3% in 2025, then sank by 128 bps to 5.24% in 2026.
- Business Quant data shows HBIO's FCF Margin at 5.24% in Q1 2026, 2.3% in Q4 2025, and 4.26% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 32.79% |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 12.70% |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 4.82% |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 27.57% |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | 7.86% |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 9.26% |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 6.52% |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | 8.91% |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 6.11% |
| 10 | Harvard Bioscience | 34.12 Mn | 27.61 Mn | 12.63 Mn | -1.60% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.60% |
| Mar 31, 2026 | -5.24% |
| Dec 31, 2025 | -2.30% |
| Sep 30, 2025 | 4.26% |
| Jun 30, 2025 | 13.04% |
| Mar 31, 2025 | 11.36% |
| Dec 31, 2024 | 5.80% |
| Sep 30, 2024 | -7.84% |
| Jun 30, 2024 | -7.20% |
| Mar 31, 2024 | 3.09% |
| Dec 31, 2023 | 12.34% |
| Sep 30, 2023 | 16.34% |
| Jun 30, 2023 | 10.55% |
| Mar 31, 2023 | 5.30% |
| Dec 31, 2022 | 8.60% |
| Sep 30, 2022 | 0.77% |
| Jun 30, 2022 | -2.16% |
| Mar 31, 2022 | -8.54% |
| Dec 31, 2021 | -0.73% |
| Sep 30, 2021 | -3.84% |